agent.disease-and-advisory

摘要

Research publication estimating the annual deaths and hospitalisations prevented by routine childhood immunisation programs in England, demonstrating vaccine impact.

詳細內容

This research publication provides estimated annual deaths and hospitalisations prevented by routine childhood immunisation in England. The analysis quantifies the public health benefit of vaccination programs by modeling:

Diseases prevented:

• Measles, mumps, rubella (MMR)
• Diphtheria, tetanus, pertussis (whooping cough)
• Polio
• Haemophilus influenzae type b (Hib)
• Meningococcal disease
• Pneumococcal disease
• Rotavirus
• Human papillomavirus (HPV)
• Others in the routine childhood schedule

Impact metrics:

• Deaths prevented annually
• Hospitalizations averted
• Cases avoided
• Healthcare costs saved
• Long-term disability prevented

Methodology: The estimates are based on:

• Historical disease incidence before vaccine introduction
• Current vaccination coverage rates
• Vaccine effectiveness data
• Disease severity and case-fatality rates
• Demographic and epidemiological modeling

This evidence is crucial for:

• Demonstrating vaccine program value
• Supporting vaccination policy decisions
• Countering vaccine hesitancy with data
• Justifying public health investment in immunization
• International comparisons and best practice sharing

The research reinforces that childhood vaccination is one of the most cost-effective public health interventions, preventing substantial morbidity and mortality each year.

相關疾病

Measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, meningococcal disease, pneumococcal disease, rotavirus, HPV, and other vaccine-preventable diseases

---

萃取時間: 2026-02-05T22:58:00Z 資料來源: UK Health Security Agency